What are the CURB65 (Confusion, Urea, Respiratory rate, Blood pressure, age 65) criteria for assessing pneumonia severity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CURB-65 Criteria for Pneumonia Severity Assessment

What is CURB-65?

CURB-65 is a 5-point clinical scoring system that predicts mortality risk in community-acquired pneumonia by assigning one point each for: Confusion, Urea >7 mmol/L (or BUN ≥20 mg/dL), Respiratory rate ≥30 breaths/min, Blood pressure (systolic <90 mmHg or diastolic ≤60 mmHg), and age ≥65 years. 1, 2

The Five Components

Each criterion receives one point if present 1, 2:

  • C - Confusion: New disorientation to person, place, or time, or altered mental status based on a specific mental test 1, 2
  • U - Urea: Blood urea nitrogen (BUN) ≥20 mg/dL or urea >7 mmol/L 1, 2
  • R - Respiratory rate: ≥30 breaths per minute 1, 2
  • B - Blood pressure: Systolic <90 mmHg OR diastolic ≤60 mmHg 1, 2
  • 65 - Age: ≥65 years 1, 2

Note: Systolic blood pressure is the best hemodynamic predictor; diastolic pressure may be neglected in some applications. 1

Risk Stratification and Mortality Prediction

The total score ranges from 0-5 points, with corresponding mortality risks 1, 2:

  • Score 0-1: 0.7-2.1% mortality risk (low risk) 1, 2
  • Score 2: 9.2% mortality risk (moderate risk) 1, 2
  • Score 3: 14.5% mortality risk (high risk) 1, 2
  • Score 4-5: 40-57% mortality risk (very high risk) 1, 2

Clinical Decision-Making Algorithm

For site-of-care decisions, use the following approach 1, 2:

  • Score 0-1: Consider outpatient treatment (except if age ≥65 is the only criterion met, then hospitalization should be seriously considered) 1, 2
  • Score 2: Consider short hospital stay or supervised outpatient treatment; clinical judgment is particularly important in this intermediate risk group 1, 2
  • Score ≥3: Hospital admission required; assess for ICU admission 1, 2
  • Score 4-5: Hospital admission with strong consideration for ICU-level care 1, 2

When to Override the Score

CURB-65 must be used as an adjunct to clinical judgment, not as the sole determinant. 2 Consider hospitalization regardless of score when 2:

  • Septic shock requiring vasopressors (direct ICU admission)
  • Acute respiratory failure requiring intubation/mechanical ventilation (direct ICU admission)
  • Homelessness, psychiatric illness, or inability to take oral medications
  • Lack of social support or inability to ensure medication adherence
  • Comorbidity exacerbations (pneumonia worsening underlying conditions like heart failure or COPD)
  • Failure of outpatient antibiotic therapy

Advantages of CURB-65

CURB-65 is preferred for its simplicity and practicality 1, 2:

  • Uses only 5 easily remembered variables 1, 2
  • Requires only one laboratory test (urea/BUN), readily available in most hospitals 2
  • Can be calculated quickly in busy emergency departments without scoring sheets 1
  • Helps reduce unnecessary hospitalizations while ensuring appropriate care for higher-risk patients 2

CRB-65: The Simplified Version

CRB-65 omits the urea measurement and can be used when laboratory testing is unavailable, giving a score range of 0-4 points 1, 2. This variant is particularly useful in 2:

  • Primary care practitioner offices
  • Outpatient settings
  • Resource-limited environments

Important Limitations and Pitfalls

CURB-65 has specific populations where it may underestimate severity 2, 3:

  • Young patients (<65 years) with severe respiratory failure: The score may underestimate severity in previously healthy patients under 65 with significant physiologic derangement, as age is heavily weighted 2, 3
  • Elderly patients with comorbidities: May underestimate risk in patients with multiple comorbid conditions 2, 3
  • Patients with baseline renal insufficiency: The urea criterion may be less reliable 1
  • Nursing home-acquired pneumonia: CURB-65 performs poorly in this population; even CRB-80 fails to identify low-risk patients (22.75% mortality in "low-risk" group) 4

For ICU admission decisions specifically, CURB-65 performs less effectively than the IDSA/ATS severe CAP criteria, which should be used instead for ICU triage 2, 3. Direct ICU admission criteria include 2:

  • ≥3 minor criteria for severe CAP
  • Septic shock requiring vasopressors
  • Acute respiratory failure requiring mechanical ventilation
  • ≥2 of: systolic BP <90 mmHg, severe respiratory failure, multilobar involvement, or need for mechanical ventilation/vasopressors

Comparison with PSI

While both CURB-65 and the Pneumonia Severity Index (PSI) are validated tools, they have different strengths 1:

  • PSI is more complex (20 variables) but may classify slightly more patients as low-risk with similar mortality rates 1
  • CURB-65 is simpler and more practical in emergency settings 1, 2
  • PSI requires scoring sheets or computerized decision support; CURB-65 is easily remembered 1
  • Recent meta-analysis suggests CURB-65 has slightly better sensitivity (96.7%) and specificity (89.3%) for predicting ICU admission needs 5
  • Both tools have been shown to be comparable in predicting mortality 1

Implementation Best Practices

To optimize CURB-65 use in clinical practice 2:

  • Implement as part of a systematic pneumonia care bundle
  • Always combine with clinical assessment of severity (tachypnea, tachycardia, hypotension, confusion) 1
  • For patients with CURB-65 ≥3, promptly evaluate for potential ICU admission 2
  • Consider comorbidities such as HIV, diabetes, heart failure, moderate-to-severe COPD, liver disease, renal disease, or malignancy when making final decisions 1, 2
  • Expect clinical improvement within 3 days; patients should contact their physician if no improvement occurs 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Community-Acquired Pneumonia Severity Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Community-Acquired Pneumonia Mortality Risk Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.